Harry W. Alcorn Jr serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Harry W. Alcorn Jr has executed 8 insider transactions totaling $145.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 15, 2021 involved purchasing 15,000 shares valued at $57.0K.
Harry W. Alcorn Jr currently holds 43,582 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harry W. Alcorn Jr has been a net buyer of DMAC stock. They have purchased $145.1K and sold $0 worth of shares.
Harry W. Alcorn Jr's most recent insider trade was on Sep 15, 2021, when they purchased 15,000 shares at $3.80 per share.
Get notified when new Form 4 filings are submitted
| $3.09 |
| Discretionary |
| Aug 16, 2021 | DMAC | $985 | Purchase | 322 | $3.06 | Discretionary |
| Aug 16, 2021 | DMAC | $1.2K | Purchase | 399 | $3.07 | Discretionary |
| Aug 16, 2019 | DMAC | $19.4K | Purchase | 7,260 | $2.67 | Discretionary |
| Mar 28, 2019 | DMAC | $0 | Gift | 150 | $N/A | Discretionary |
| Mar 27, 2019 | DMAC | $669 | Purchase | 150 | $4.46 | Discretionary |
| Dec 11, 2018 | DMAC | $4.0K | Purchase | 1,000 | $4.00 | Discretionary |